Information Provided By:
Fly News Breaks for June 3, 2016
WBA, RAD, MCK
Jun 3, 2016 | 07:38 EDT
FBR Capital analyst Steven Halper estimates McKesson's information technology unit produces about $1.20 per share in annual earnings. After the Wall Street Journal reported last night that the company is weighing the sale of the unit, Halper tells investors that the challenge for McKesson would be how it would replace the earnings. The company could redeploy capital through acquisitions, share repurchases and increasing its cash dividend, the analyst writes. He reminds investors that McKesson still faces a potential new headwind in FY18 if Walgreens (WBA) closes its proposed merger with Rite Aid (RAD). Halper keeps an Outperform rating on McKesson.
News For MCK;RAD;WBA From the Last 2 Days
WBA
Mar 28, 2024 | 12:00 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
WBA
Mar 28, 2024 | 08:59 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
WBA
Mar 28, 2024 | 07:12 EDT
Consensus $3.24. The company said the change reflects challenging retail environment in the U.S., early wind-down of sale-leaseback program, and lower earnings due to Cencora share sales, offset by execution in pharmacy services and a lower adjusted effective tax rate. The company is also maintaining its U.S. Healthcare adjusted EBITDA view to be breakeven at the midpoint of the guidance range of loss of $50M to gain of $50M.
WBA
Mar 28, 2024 | 07:05 EDT
Reports Q2 revenue $37.05B, consensus $35.86B. The company said, "We're encouraged by our first quarter of U.S. Healthcare positive adjusted EBITDA and continued topline growth alongside another quarter of strong execution in pharmacy, as we look to re-energize and evolve its impact both at Walgreens and at large. As we continue to operate in a challenging retail environment, we are taking actions to focus on customer engagement and value.We remain confident in our goal of achieving $1 billion in cost savings this year. We are continuing to strategically review our portfolio over the next three months in an effort to ensure it drives growth and delivers value. Our team members, led by WBA's new executive committee with a track record of operational excellence, are powering our progress as we map growth opportunities, aim to create long-term value across our businesses and execute the hard work to simplify and strengthen WBA."
WBA
Mar 27, 2024 | 13:20 EDT
Notable companies reporting before tomorrow's open, with earnings consensus, include Walgreens Boots Alliance (WBA), consensus 82c.
WBA
Mar 26, 2024 | 06:33 EDT
Morgan Stanley lowered the firm's price target on Walgreens Boots Alliance to $21 from $22 and keeps an Underweight rating on the shares. Ahead of the company's Q2 report, the firm is tempering its FY24 EPS estimate to $3.24 from $3.35 to reflect a variable consumer backdrop. While "hopeful" about Walgreens' turnaround prospects, cost cutting, and pruning of assets, the firm awaits detail on the new CEO's vision and tells investors it is "still likely too early."